Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini oral session: Haematological malignancies

332MO - Long-term toxicities after allogeneic HSCT with or without total body irradiation: A population-based study in Korea

Date

03 Dec 2023

Session

Mini oral session: Haematological malignancies

Topics

Tumour Site

Leukaemias

Presenters

Byoung Hyuck Kim

Citation

Annals of Oncology (2023) 34 (suppl_4): S1599-S1606. 10.1016/annonc/annonc1384

Authors

B.H. Kim1, J. Kwon2

Author affiliations

  • 1 Radiation Oncology, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, 156-707 - Seoul/KR
  • 2 Radiation Oncology, Chungnam National University Hospital, 301-721 - Daejeon/KR

Resources

This content is available to ESMO members and event participants.

Abstract 332MO

Background

To compare long-term toxicity incidences, including secondary cancer (Sec.ca) with or without TBI, in Asian patients receiving allogeneic hematopoietic stem cell transplantation (HSCT) using a nationwide database.

Methods

We identified 4,554 patients receiving HSCT for leukemic disease from 2009 to 2016 using the Healthcare Bigdata system of Korea. Incidence rate ratios (IRRs) for Sec.Ca, cataracts, hypothyroidism, chronic kidney disease (CKD), myocardial infarctions (MIs), or strokes were compared, and standardized incidence ratios (SIR) of Sec.ca was also estimated.

Results

TBI was conducted on 1,409 patients (30.9%). No overall survival differences based on TBI were observed. With a median follow-up duration of 58.2 months, 143 patients were diagnosed with subsequent Sec.Ca (3.4%). Incidence rates per 1000 Person-Year (95% CI) were 6.56(4.75–8.84) and 7.23(5.89–8.80) in the TBI and no-TBI groups, respectively (p=.594). Also, the SIR (95% CI) was not significantly increased by TBI [1.32(0.86–1.94) vs. 1.39(1.08–1.77) in the no-TBI group]. In the young age group (0-19 years), SIRs were increased in both groups regardless of TBI (8.60 vs. 11.96). The IRRs (95% CI) of cataracts [1.60(1.30–1.95)], CKD [1.85(1.31–2.62)], and hypothyroidism [1.50(1.07–2.09)] were significantly increased after TBI. However, there were no significant differences in the occurrence of MI and stroke according to TBI.

Conclusions

Our results suggest that modern TBI may not additionally increase the risk of Sec.ca after allogeneic HSCT, although increased risks of other diseases were noted. Physicians should carefully consider individualized risks and benefits of TBI, with a particular focus by age group.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The author.

Funding

Chungnam National Universit.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.